72 related articles for article (PubMed ID: 10463522)
1. Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study.
O'Connor CM; Radensky PW; Unger AN; Martin BC
Clin Ther; 1999 Jul; 21(7):1254-65. PubMed ID: 10463522
[TBL] [Abstract][Full Text] [Related]
2. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
Packer M; O'Connor CM; Ghali JK; Pressler ML; Carson PE; Belkin RN; Miller AB; Neuberg GW; Frid D; Wertheimer JH; Cropp AB; DeMets DL
N Engl J Med; 1996 Oct; 335(15):1107-14. PubMed ID: 8813041
[TBL] [Abstract][Full Text] [Related]
3. Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.
Wijeysundera HC; Hansen MS; Stanton E; Cropp AS; Hall C; Dhalla NS; Ghali J; Rouleau JL;
Am Heart J; 2003 Aug; 146(2):291-7. PubMed ID: 12891198
[TBL] [Abstract][Full Text] [Related]
4. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
5. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
6. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).
Packer M; Carson P; Elkayam U; Konstam MA; Moe G; O'Connor C; Rouleau JL; Schocken D; Anderson SA; DeMets DL;
JACC Heart Fail; 2013 Aug; 1(4):308-314. PubMed ID: 24621933
[TBL] [Abstract][Full Text] [Related]
7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
8. A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in Sweden.
Doyle JJ; McGuire A; Arocho R; Arikian S; Casciano J; Svangren P; Casciano R; Kim R; Kugel H
Int J Clin Pract; 2002 Mar; 56(2):76-81. PubMed ID: 11926709
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials.
Janicak PG; Wu JH; Mao L
Curr Med Res Opin; 2008 Jun; 24(6):1807-15. PubMed ID: 18559166
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
11. Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy.
Menzin J; Boulanger L; Tang S; Thakker K; Nissen SE
Appl Health Econ Health Policy; 2008; 6(2-3):157-62. PubMed ID: 19231908
[TBL] [Abstract][Full Text] [Related]
12. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
13. Statin therapy is associated with lower mortality among patients with severe heart failure.
Mozaffarian D; Nye R; Levy WC
Am J Cardiol; 2004 May; 93(9):1124-9. PubMed ID: 15110204
[TBL] [Abstract][Full Text] [Related]
14. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
15. The pharmacoeconomic impact of amlodipine use on coronary artery disease.
De Portu S; Menditto E; Scalone L; Bustacchini S; Cricelli C; Mantovani LG
Pharmacol Res; 2006 Aug; 54(2):158-63. PubMed ID: 16814560
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
[TBL] [Abstract][Full Text] [Related]
18. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiologic evaluation of cardiac decompensation and its impact on health costs].
Bilora F; Vettore G; Saccaro G; Barbata A; Dei Rossi C; Petrobelli F
Minerva Cardioangiol; 1998; 46(7-8):235-9. PubMed ID: 9973786
[TBL] [Abstract][Full Text] [Related]
20. [Amlodipine in heart failure: initial results of the PRAISE study].
Steffen HM
Herz; 1995 Aug; 20 Suppl 2():3-4. PubMed ID: 7557834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
